{"id":"https://openalex.org/W2087793743","doi":"https://doi.org/10.1089/cbr.2005.20.189","title":"The Potential Use of 99m Tc-MDP Bone Scans to Plan High-Activity 186 Re-HEDP Targeted Therapy of Bony Metastases from Prostate Cancer","display_name":"The Potential Use of 99m Tc-MDP Bone Scans to Plan High-Activity 186 Re-HEDP Targeted Therapy of Bony Metastases from Prostate Cancer","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W2087793743","doi":"https://doi.org/10.1089/cbr.2005.20.189","mag":"2087793743","pmid":"https://pubmed.ncbi.nlm.nih.gov/15869454"},"language":"en","primary_location":{"id":"doi:10.1089/cbr.2005.20.189","doi":"https://doi.org/10.1089/cbr.2005.20.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.2005.20.189","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084226326","display_name":"David Binnie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Binnie","raw_affiliation_strings":["Imperial College of Science Technology and Medicine, London, United Kingdom","Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College of Science Technology and Medicine, London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057407518","display_name":"Antigoni Divoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Antigoni Divoli","raw_affiliation_strings":["Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008070430","display_name":"Victor Ralph McCready","orcid":"https://orcid.org/0000-0002-3677-3801","observed_orcids":["https://orcid.org/0000-0002-3677-3801"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"V. Ralph McCready","raw_affiliation_strings":["Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025921361","display_name":"David Paul Dearnaley","orcid":"https://orcid.org/0000-0002-3954-2806","observed_orcids":["https://orcid.org/0000-0002-3954-2806"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Dearnaley","raw_affiliation_strings":["Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081540359","display_name":"Glenn Flux","orcid":"https://orcid.org/0000-0003-4743-2276","observed_orcids":["https://orcid.org/0000-0003-4743-2276"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Glenn Flux","raw_affiliation_strings":["Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital Foundation Trust, Sutton, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2429,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.62257112,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"20","issue":"2","first_page":"189","last_page":"194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/99mtc-mdp-bone-scintigraphy","display_name":"99mTc-MDP bone scintigraphy","score":0.902999997138977},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.6110000014305115},{"id":"https://openalex.org/keywords/prostate-cancer-bone-metastasis","display_name":"prostate cancer bone metastasis","score":0.8420000076293945},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-planning","display_name":"treatment planning","score":0.6320000290870667},{"id":"https://openalex.org/keywords/absorbed-dose-calculation","display_name":"absorbed dose estimation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/radiopharmaceutical-biodistribution","display_name":"radiopharmaceutical biodistribution","score":0.6880000233650208},{"id":"https://openalex.org/keywords/bone-turnover","display_name":"bone turnover","score":0.5040000081062317},{"id":"https://openalex.org/keywords/physical-decay","display_name":"physical decay","score":0.3240000009536743},{"id":"https://openalex.org/keywords/stem-cell-support","display_name":"stem cell support","score":0.4650000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.728185772895813},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7235668897628784},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.6782160401344299},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5369825959205627},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5280694961547852},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4162932336330414},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.41461899876594543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.263083815574646}],"mesh":[{"descriptor_ui":"D001842","descriptor_name":"Bone and Bones","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007091","descriptor_name":"Image Processing, Computer-Assisted","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009942","descriptor_name":"Organometallic Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012968","descriptor_name":"Etidronic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012984","descriptor_name":"Software","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013669","descriptor_name":"Technetium Tc 99m Medronate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014915","descriptor_name":"Whole-Body Counting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016719","descriptor_name":"Radioimmunodetection","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/cbr.2005.20.189","doi":"https://doi.org/10.1089/cbr.2005.20.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cbr.2005.20.189","pdf_url":null,"source":{"id":"https://openalex.org/S87235987","display_name":"Cancer Biotherapy and Radiopharmaceuticals","issn_l":"1084-9785","issn":["1084-9785","1557-8852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biotherapy and Radiopharmaceuticals","raw_type":"journal-article"},{"id":"pmid:15869454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15869454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biotherapy & radiopharmaceuticals","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1966727387","https://openalex.org/W2010027532","https://openalex.org/W2070550035","https://openalex.org/W2082164670","https://openalex.org/W2092389226","https://openalex.org/W2118828860","https://openalex.org/W2346874390"],"related_works":["https://openalex.org/W327266640","https://openalex.org/W2074209299","https://openalex.org/W1900654240","https://openalex.org/W2320009904","https://openalex.org/W1965435542","https://openalex.org/W2009065700","https://openalex.org/W2325444673","https://openalex.org/W2611314842","https://openalex.org/W2266547198","https://openalex.org/W7096485422"],"abstract_inverted_index":{"Patients":[0],"with":[1,15,43,84],"skeletal":[2],"metastases":[3],"from":[4],"hormone-refractory":[5],"prostate":[6],"cancer":[7],"have":[8],"shown":[9],"variable":[10],"responses":[11],"to":[12,34,48,124],"high-activity":[13],"therapy":[14,41],"(186)Re-HEDP":[16,108],"and":[17,57,107],"peripheral":[18],"stem":[19],"cell":[20],"support.":[21],"In":[22],"this":[23],"paper,":[24],"we":[25],"report":[26],"on":[27],"the":[28,50,53,64,72,82,85,95,102,105,111,115],"use":[29],"of":[30,52,71,81,104,113,121,130],"a":[31,75,98],"novel":[32],"technique":[33],"compare":[35],"sequential":[36],"planar":[37],"images":[38],"acquired":[39],"post-(186)Re-HEDP":[40],"administration":[42],"pretherapy":[44,116],"diagnostic":[45],"(99m)Tc-MDP":[46,106],"scans,":[47],"evaluate":[49],"turnover":[51],"radiopharmaceutical":[54],"in":[55,66,101],"normal":[56,67],"abnormal":[58],"bone.":[59],"It":[60],"was":[61],"found":[62],"that":[63,80],"activity":[65],"(i.e.,":[68],"disease-free)":[69],"segments":[70],"spine":[73],"demonstrates":[74],"faster":[76],"effective":[77],"decay":[78],"than":[79],"metastases,":[83],"latter":[86],"showing":[87],"only":[88],"physical":[89],"decay.":[90],"This":[91],"study":[92],"showed,":[93],"for":[94,119],"first":[96],"time,":[97],"detailed":[99],"correlation":[100],"behavior":[103],"images,":[109],"encouraging":[110],"possibility":[112],"using":[114],"99mTc-MDP":[117],"scan":[118],"estimations":[120],"absorbed":[122],"doses":[123],"be":[125],"delivered":[126],"by":[127],"prescribed":[128],"activities":[129],"(186)Re-HEDP.":[131]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}